This report aims to provide a comprehensive presentation of the global market for Predisposition Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Predisposition Biomarkers. This report contains market size and forecasts of Predisposition Biomarkers in global, including the following market information:
Global Predisposition Biomarkers Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Predisposition Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Sepsis Biomarkers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Predisposition Biomarkers include QIAGEN, Bio-Rad Laboratories, Epigenomics AG, Roche Diagnostics, Myriad Genetics, Almac Group and US Biomarkers Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Predisposition Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Predisposition Biomarkers Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Predisposition Biomarkers Market Segment Percentages, by Type, 2022 (%)
- Sepsis Biomarkers
- Antibiotic Resistance Biomarkers
- Traumatic Brain Injury (TBI) Testing Biomarkers
- Stroke Testing Biomarkers
- Antibiotic Stewardship Biomarkers
- Other
Global Predisposition Biomarkers Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Predisposition Biomarkers Market Segment Percentages, by Application, 2022 (%)
- Hospitals
- Contract Research Organizations
- Academic Research Institutes
Global Predisposition Biomarkers Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Predisposition Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Predisposition Biomarkers revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Predisposition Biomarkers revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- QIAGEN
- Bio-Rad Laboratories
- Epigenomics AG
- Roche Diagnostics
- Myriad Genetics
- Almac Group
- US Biomarkers Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Predisposition Biomarkers, market overview.
Chapter 2: Global Predisposition Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Predisposition Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Predisposition Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Predisposition Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Predisposition Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Predisposition Biomarkers Overall Market Size
2.1 Global Predisposition Biomarkers Market Size: 2022 VS 2029
2.2 Global Predisposition Biomarkers Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Predisposition Biomarkers Players in Global Market
3.2 Top Global Predisposition Biomarkers Companies Ranked by Revenue
3.3 Global Predisposition Biomarkers Revenue by Companies
3.4 Top 3 and Top 5 Predisposition Biomarkers Companies in Global Market, by Revenue in 2022
3.5 Global Companies Predisposition Biomarkers Product Type
3.6 Tier 1, Tier 2 and Tier 3 Predisposition Biomarkers Players in Global Market
3.6.1 List of Global Tier 1 Predisposition Biomarkers Companies
3.6.2 List of Global Tier 2 and Tier 3 Predisposition Biomarkers Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Predisposition Biomarkers Market Size Markets, 2022 & 2029
4.1.2 Sepsis Biomarkers
4.1.3 Antibiotic Resistance Biomarkers
4.1.4 Traumatic Brain Injury (TBI) Testing Biomarkers
4.1.5 Stroke Testing Biomarkers
4.1.6 Antibiotic Stewardship Biomarkers
4.1.7 Other
4.2 By Type - Global Predisposition Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Predisposition Biomarkers Revenue, 2018-2023
4.2.2 By Type - Global Predisposition Biomarkers Revenue, 2024-2029
4.2.3 By Type - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Predisposition Biomarkers Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Contract Research Organizations
5.1.4 Academic Research Institutes
5.2 By Application - Global Predisposition Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Predisposition Biomarkers Revenue, 2018-2023
5.2.2 By Application - Global Predisposition Biomarkers Revenue, 2024-2029
5.2.3 By Application - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Predisposition Biomarkers Market Size, 2022 & 2029
6.2 By Region - Global Predisposition Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Predisposition Biomarkers Revenue, 2018-2023
6.2.2 By Region - Global Predisposition Biomarkers Revenue, 2024-2029
6.2.3 By Region - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Predisposition Biomarkers Revenue, 2018-2029
6.3.2 US Predisposition Biomarkers Market Size, 2018-2029
6.3.3 Canada Predisposition Biomarkers Market Size, 2018-2029
6.3.4 Mexico Predisposition Biomarkers Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Predisposition Biomarkers Revenue, 2018-2029
6.4.2 Germany Predisposition Biomarkers Market Size, 2018-2029
6.4.3 France Predisposition Biomarkers Market Size, 2018-2029
6.4.4 U.K. Predisposition Biomarkers Market Size, 2018-2029
6.4.5 Italy Predisposition Biomarkers Market Size, 2018-2029
6.4.6 Russia Predisposition Biomarkers Market Size, 2018-2029
6.4.7 Nordic Countries Predisposition Biomarkers Market Size, 2018-2029
6.4.8 Benelux Predisposition Biomarkers Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Predisposition Biomarkers Revenue, 2018-2029
6.5.2 China Predisposition Biomarkers Market Size, 2018-2029
6.5.3 Japan Predisposition Biomarkers Market Size, 2018-2029
6.5.4 South Korea Predisposition Biomarkers Market Size, 2018-2029
6.5.5 Southeast Asia Predisposition Biomarkers Market Size, 2018-2029
6.5.6 India Predisposition Biomarkers Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Predisposition Biomarkers Revenue, 2018-2029
6.6.2 Brazil Predisposition Biomarkers Market Size, 2018-2029
6.6.3 Argentina Predisposition Biomarkers Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Predisposition Biomarkers Revenue, 2018-2029
6.7.2 Turkey Predisposition Biomarkers Market Size, 2018-2029
6.7.3 Israel Predisposition Biomarkers Market Size, 2018-2029
6.7.4 Saudi Arabia Predisposition Biomarkers Market Size, 2018-2029
6.7.5 UAE Predisposition Biomarkers Market Size, 2018-2029
7 Predisposition Biomarkers Companies Profiles
7.1 QIAGEN
7.1.1 QIAGEN Company Summary
7.1.2 QIAGEN Business Overview
7.1.3 QIAGEN Predisposition Biomarkers Major Product Offerings
7.1.4 QIAGEN Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.1.5 QIAGEN Key News & Latest Developments
7.2 Bio-Rad Laboratories
7.2.1 Bio-Rad Laboratories Company Summary
7.2.2 Bio-Rad Laboratories Business Overview
7.2.3 Bio-Rad Laboratories Predisposition Biomarkers Major Product Offerings
7.2.4 Bio-Rad Laboratories Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Laboratories Key News & Latest Developments
7.3 Epigenomics AG
7.3.1 Epigenomics AG Company Summary
7.3.2 Epigenomics AG Business Overview
7.3.3 Epigenomics AG Predisposition Biomarkers Major Product Offerings
7.3.4 Epigenomics AG Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.3.5 Epigenomics AG Key News & Latest Developments
7.4 Roche Diagnostics
7.4.1 Roche Diagnostics Company Summary
7.4.2 Roche Diagnostics Business Overview
7.4.3 Roche Diagnostics Predisposition Biomarkers Major Product Offerings
7.4.4 Roche Diagnostics Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.4.5 Roche Diagnostics Key News & Latest Developments
7.5 Myriad Genetics
7.5.1 Myriad Genetics Company Summary
7.5.2 Myriad Genetics Business Overview
7.5.3 Myriad Genetics Predisposition Biomarkers Major Product Offerings
7.5.4 Myriad Genetics Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.5.5 Myriad Genetics Key News & Latest Developments
7.6 Almac Group
7.6.1 Almac Group Company Summary
7.6.2 Almac Group Business Overview
7.6.3 Almac Group Predisposition Biomarkers Major Product Offerings
7.6.4 Almac Group Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.6.5 Almac Group Key News & Latest Developments
7.7 US Biomarkers Inc
7.7.1 US Biomarkers Inc Company Summary
7.7.2 US Biomarkers Inc Business Overview
7.7.3 US Biomarkers Inc Predisposition Biomarkers Major Product Offerings
7.7.4 US Biomarkers Inc Predisposition Biomarkers Revenue in Global Market (2018-2023)
7.7.5 US Biomarkers Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Predisposition Biomarkers Market Opportunities & Trends in Global Market
Table 2. Predisposition Biomarkers Market Drivers in Global Market
Table 3. Predisposition Biomarkers Market Restraints in Global Market
Table 4. Key Players of Predisposition Biomarkers in Global Market
Table 5. Top Predisposition Biomarkers Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Predisposition Biomarkers Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Predisposition Biomarkers Revenue Share by Companies, 2018-2023
Table 8. Global Companies Predisposition Biomarkers Product Type
Table 9. List of Global Tier 1 Predisposition Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Predisposition Biomarkers Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Predisposition Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Predisposition Biomarkers Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Predisposition Biomarkers Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Predisposition Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Predisposition Biomarkers Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Predisposition Biomarkers Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Predisposition Biomarkers Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Predisposition Biomarkers Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Predisposition Biomarkers Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Predisposition Biomarkers Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Predisposition Biomarkers Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Predisposition Biomarkers Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Predisposition Biomarkers Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Predisposition Biomarkers Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Predisposition Biomarkers Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Predisposition Biomarkers Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Predisposition Biomarkers Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Predisposition Biomarkers Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Predisposition Biomarkers Revenue, (US$, Mn), 2024-2029
Table 30. QIAGEN Company Summary
Table 31. QIAGEN Predisposition Biomarkers Product Offerings
Table 32. QIAGEN Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 33. QIAGEN Key News & Latest Developments
Table 34. Bio-Rad Laboratories Company Summary
Table 35. Bio-Rad Laboratories Predisposition Biomarkers Product Offerings
Table 36. Bio-Rad Laboratories Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 37. Bio-Rad Laboratories Key News & Latest Developments
Table 38. Epigenomics AG Company Summary
Table 39. Epigenomics AG Predisposition Biomarkers Product Offerings
Table 40. Epigenomics AG Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 41. Epigenomics AG Key News & Latest Developments
Table 42. Roche Diagnostics Company Summary
Table 43. Roche Diagnostics Predisposition Biomarkers Product Offerings
Table 44. Roche Diagnostics Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Diagnostics Key News & Latest Developments
Table 46. Myriad Genetics Company Summary
Table 47. Myriad Genetics Predisposition Biomarkers Product Offerings
Table 48. Myriad Genetics Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 49. Myriad Genetics Key News & Latest Developments
Table 50. Almac Group Company Summary
Table 51. Almac Group Predisposition Biomarkers Product Offerings
Table 52. Almac Group Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 53. Almac Group Key News & Latest Developments
Table 54. US Biomarkers Inc Company Summary
Table 55. US Biomarkers Inc Predisposition Biomarkers Product Offerings
Table 56. US Biomarkers Inc Predisposition Biomarkers Revenue (US$, Mn) & (2018-2023)
Table 57. US Biomarkers Inc Key News & Latest Developments
List of Figures
Figure 1. Predisposition Biomarkers Segment by Type in 2022
Figure 2. Predisposition Biomarkers Segment by Application in 2022
Figure 3. Global Predisposition Biomarkers Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Predisposition Biomarkers Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Predisposition Biomarkers Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Predisposition Biomarkers Revenue in 2022
Figure 8. By Type - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 9. By Application - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 10. By Type - Global Predisposition Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 12. By Application - Global Predisposition Biomarkers Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 14. By Region - Global Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 15. By Country - North America Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 16. US Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 20. Germany Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 21. France Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 28. China Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 32. India Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 34. Brazil Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Predisposition Biomarkers Revenue Market Share, 2018-2029
Figure 37. Turkey Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Predisposition Biomarkers Revenue, (US$, Mn), 2018-2029
Figure 41. QIAGEN Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bio-Rad Laboratories Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Epigenomics AG Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Diagnostics Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Myriad Genetics Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Almac Group Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. US Biomarkers Inc Predisposition Biomarkers Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
